Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Vaccine - Page 47

Vaccine

Moderna announced publication in the NEJM of non-human primate preclinical viral challenge study of its mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced publication in the NEJM of non-human primate preclinical viral challenge study of its mRNA vaccine against COVID-19

On Jul. 28, 2020, Moderna announced a preclinical study evaluating mRNA-1273, its vaccine candidate against COVID-19, was published…

Read More Moderna announced publication in the NEJM of non-human primate preclinical viral challenge study of its mRNA vaccine against COVID-19Continue

Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
Biotechnology | COVID-19 | Therapeutics | Vaccine

Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine

On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax program (heat stable COVID-19…

Read More Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccineContinue

Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
Biotechnology | COVID-19 | Therapeutics | Vaccine

Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine

On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…

Read More Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccineContinue

Phase 3 clinical trial of investigational vaccine for COVID-19 began
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Phase 3 clinical trial of investigational vaccine for COVID-19 began

On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…

Read More Phase 3 clinical trial of investigational vaccine for COVID-19 beganContinue

Serum Institute conducted phase III clinical trial of BCG vaccine
COVID-19 | Life Science History | Vaccine

Serum Institute conducted phase III clinical trial of BCG vaccine

On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…

Read More Serum Institute conducted phase III clinical trial of BCG vaccineContinue

Amyris and the Infectious Disease Research Institute partnered to advance novel RNA vaccine platform beginning with COVID-19 application
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

Amyris and the Infectious Disease Research Institute partnered to advance novel RNA vaccine platform beginning with COVID-19 application

On Jul. 27, 2020, Amyris and the Infectious Disease Research Institute (IDRI) announced the signing of a binding…

Read More Amyris and the Infectious Disease Research Institute partnered to advance novel RNA vaccine platform beginning with COVID-19 applicationContinue

Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 caccine candidate
COVID-19 | Life Science History | Vaccine

Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 caccine candidate

On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…

Read More Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 caccine candidateContinue

MediciNova announced SARS-CoV-2 vaccine joint development with BioComo and Mie University Japan
Biotechnology | Infectious Disease | Influenza | Vaccine

MediciNova announced SARS-CoV-2 vaccine joint development with BioComo and Mie University Japan

On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…

Read More MediciNova announced SARS-CoV-2 vaccine joint development with BioComo and Mie University JapanContinue

Moderna announced phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) began
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) began

On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…

Read More Moderna announced phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) beganContinue

Texas A&M College Station Bio-Manufacturing Center to produce COVID-19 vaccines
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Texas A&M College Station Bio-Manufacturing Center to produce COVID-19 vaccines

On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…

Read More Texas A&M College Station Bio-Manufacturing Center to produce COVID-19 vaccinesContinue

Moderna announced expansion of BARDA agreement to support larger phase 3 program for vaccine (mRNA-1273) against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced expansion of BARDA agreement to support larger phase 3 program for vaccine (mRNA-1273) against COVID-19

On Jul. 26, 2020, Moderna announced a modification to its contract with the Biomedical Advanced Research and Development…

Read More Moderna announced expansion of BARDA agreement to support larger phase 3 program for vaccine (mRNA-1273) against COVID-19Continue

Intravacc and Leiden University developed an animal replacement method for vaccines
Life Science History | Vaccine

Intravacc and Leiden University developed an animal replacement method for vaccines

On Jul. 23, 2020, Intravacc announced the publication of a study in Scientific Reports on alternatives to the…

Read More Intravacc and Leiden University developed an animal replacement method for vaccinesContinue

Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate

On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…

Read More Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidateContinue

Medigen Vaccines collaborated with Dynavax to develop novel adjuvanted COVID-19 vaccine candidate
Biotechnology | COVID-19 | FDA | Medicine | Therapeutics | Vaccine

Medigen Vaccines collaborated with Dynavax to develop novel adjuvanted COVID-19 vaccine candidate

On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics (MVC) announced a collaboration to develop an adjuvanted…

Read More Medigen Vaccines collaborated with Dynavax to develop novel adjuvanted COVID-19 vaccine candidateContinue

Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19
COVID-19 | Life Science History | Vaccine

Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19

On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneメs single-dose intranasal vaccine…

Read More Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19Continue

Experimental Coronavirus vaccine is safe and produced immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental Coronavirus vaccine is safe and produced immune response

On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…

Read More Experimental Coronavirus vaccine is safe and produced immune responseContinue

GSK and CureVac announced strategic mRNA technology collaboration
Life Science History | Vaccine

GSK and CureVac announced strategic mRNA technology collaboration

On Jul. 21, 2020, GlaxoSmithKline and CureVac announced a strategic collaboration agreement for the research, development, manufacturing and…

Read More GSK and CureVac announced strategic mRNA technology collaborationContinue

Experimental coronavirus vaccine reported safe and produces immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental coronavirus vaccine reported safe and produces immune response

On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…

Read More Experimental coronavirus vaccine reported safe and produces immune responseContinue

COVID-19 vaccine trials conducted at Washington University, Saint Louis University
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

COVID-19 vaccine trials conducted at Washington University, Saint Louis University

On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…

Read More COVID-19 vaccine trials conducted at Washington University, Saint Louis UniversityContinue

BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations
Diagnostics | Medical Device | Vaccine

BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations

On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….

Read More BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparationsContinue

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine

On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…

Read More The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccineContinue

Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program
COVID-19 | Life Science History | Vaccine

Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program

On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…

Read More Valneva confirmed participation in UK Government COVID-19 Vaccine Response ProgramContinue

Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2
Life Science History | Vaccine

Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2

On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…

Read More Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2Continue

Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study
Life Science History | Vaccine

Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study

On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…

Read More Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine studyContinue

Thermo Fisher Scientific’s to support development and production of  COVID-19 therapeutics and vaccines
COVID-19 | Life Science History | Vaccine

Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines

On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…

Read More Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccinesContinue

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection
COVID-19 | Life Science History | Nanotechnology | Vaccine

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection

On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…

Read More HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injectionContinue

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials
COVID-19 | Life Science History | Vaccine

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials

On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…

Read More HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trialsContinue

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
COVID-19 | Life Science History | Vaccine

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…

Read More Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19Continue

Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvant
Biotechnology | Infectious Disease | Influenza | Vaccine

Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvant

On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…

Read More Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvantContinue

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics

On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…

Read More Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeuticsContinue

Page navigation

Previous PagePrevious 1 … 45 46 47 48 49 … 73 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search